US Market Report Suite for Diabetes Monitoring, Treatment and Drug Delivery 2017 - MedSuite

 Published On: Oct, 2016 |    No of Pages: 446 |  Published By: iData Research Inc | Format: PDF
Request Free Sample
Diabetes mellitus is a multifaceted disease that yields various approaches in terms of diagnosis, treatment and drug delivery. Products for maintenance and treatment of diabetes can be of high volume and low cost or of relatively low volume and high cost. The U.S. diabetes monitoring, treatment and drug delivery market increased in value in 2016 and growth is expected to persist over the forecast period. Growth will be driven by the increasing prevalence of diabetes in the U.S. and technological advancements made in certain segments, particularly insulin pumps and continuous glucose monitoring (CGM). Limitations to market growth include pricing pressure due to recent CMS reimbursement changes and the negative impact on the overall blood glucose monitoring market. The recent influx of low-price competitors in the blood glucose test strip segment has also placed downward pressure on prices and resulted in market value contractions despite the growing volume and increasing number of diabetics testing their blood glucose levels.

The full report suite on the U.S. market for diabetes monitoring, treatment and drug delivery includes blood glucose meters, blood glucose test strips, lancets and lancing devices, continuous glucose monitoring (CGM), insulin, inulin pens, insulin syringes and insulin pumps. Sanofi and Novo Nordisk recently launched next-generation insulin products: insulin glargine U-300 (Toujeo®) and insulin degludec (Tresiba®), respectively. Both of these insulin analogs are “ultra-long-acting” and have an average duration of 24 to 36 hours, which means that patients will only be required to perform once-daily injections. Novo Nordisk is currently developing Ryzodeg®, a premixed insulin analog comprising insulin degludec (Tresiba®) and insulin aspart (NovoLog®), in addition to an “ultra-rapid-acting” insulin analog, which are both expected to be launched during the forecast period. The insulin-dependent patient population is expected to transition to next-generation insulin products and will contribute to the growth of the insulin market and associated insulin delivery markets.
TABLE OF CONTENTS I
LIST OF FIGURES VII
LIST OF CHARTS XI
EXECUTIVE SUMMARY 1
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 1
COMPETITIVE ANALYSIS 4
MARKET TRENDS 7
MARKET DEVELOPMENTS 9
PROCEDURE NUMBERS 10
PROCEDURE CODES INVESTIGATED 11
MARKETS INCLUDED 12
KEY REPORT UPDATES 14
VERSION HISTORY 14
RESEARCH METHODOLOGY 15
1.1 RESEARCH SCOPE 15
1.2 IDATA'S 9-STEP METHODOLOGY 15
Step 1: Project Initiation & Team Selection 15
Step 2: Prepare Data Systems and Perform Secondary Research 17
Step 3: Preparation for Interviews & Questionnaire Design 18
Step 4: Performing Primary Research 19
Step 5: Research Analysis: Establishing Baseline Estimates 21
Step 6: Market Forecast and Analysis 22
Step 7: Identify Strategic Opportunities 24
Step 8: Final Review and Market Release 25
Step 9: Customer Feedback and Market Monitoring 26
DISEASE OVERVIEW 27
2.1 INTRODUCTION 27
2.1.1 Types of Diabetes 27
2.1.2 Diabetes Complications 29
2.1.3 Risk Factors Associated with Type 1 and Type 2 Diabetes 31
2.1.4 Signs and Symptoms 32
2.1.5 Diabetes Monitoring 34
2.1.6 Treatment 36
2.1.7 Drug Delivery Systems 37
U.S. DIABETES MONITORING, TREATMENT AND DRUG DELIVERY MARKET OVERVIEW 39
3.1 MARKET OVERVIEW 39
3.2 TREND ANALYSIS 45
3.3 DRIVERS AND LIMITERS 49
3.3.1 Market Drivers 49
3.3.2 Market Limiters 50
3.4 COMPETITIVE MARKET SHARE ANALYSIS 53
3.5 MERGERS AND ACQUISITIONS 57
BLOOD GLUCOSE METER MARKET 58
4.1 INTRODUCTION 58
4.2 MARKET OVERVIEW 60
4.3 MARKET ANALYSIS AND FORECAST 64
4.3.1 Total Blood Glucose Meter Market 64
4.3.1.1 Personal Blood Glucose Meter Market 66
4.3.1.2 Professional Blood Glucose Meter Market 69
4.4 DRIVERS AND LIMITERS 71
4.4.1 Market Drivers 71
4.4.2 Market Limiters 71
4.5 COMPETITIVE MARKET SHARE ANALYSIS 74
BLOOD GLUCOSE TEST STRIP MARKET 78
5.1 INTRODUCTION 78
5.2 MARKET OVERVIEW 79
5.3 MARKET ANALYSIS AND FORECAST 83
5.3.1 Total Blood Glucose Test Strip Market 83
5.3.2 Total Personal Blood Glucose Test Strip Market 85
5.3.2.1 Medicare/Medicaid Blood Glucose Test Strip Market 89
5.3.2.2 Managed Care Blood Glucose Test Strip Market 91
5.3.2.3 Cash Blood Glucose Test Strip Market 93
5.3.3 Professional Blood Glucose Test Strip Market 95
5.4 DRIVERS AND LIMITERS 97
5.4.1 Market Drivers 97
5.4.2 Market Limiters 98
5.5 COMPETITIVE MARKET SHARE ANALYSIS 100
LANCET AND LANCING DEVICE MARKET 104
6.1 INTRODUCTION 104
6.2 MARKET OVERVIEW 106
6.3 MARKET ANALYSIS AND FORECAST 109
6.3.1 Total Lancet and Lancing Device Market 109
6.3.1.1 Personal Lancet and Lancing Device Market 111
6.3.1.2 Professional Lancet and Lancing Device Market 114
6.4 DRIVERS AND LIMITERS 116
6.4.1 Market Drivers 116
6.4.2 Market Limiters 116
6.5 COMPETITIVE MARKET SHARE ANALYSIS 119
CONTINUOUS GLUCOSE MONITORING MARKET 123
7.1 INTRODUCTION 123
7.2 MARKET OVERVIEW 125
7.3 MARKET ANALYSIS AND FORECAST 129
7.3.1 Total Personal Continuous Glucose Monitoring Market 129
7.3.1.1 Personal Continuous Glucose Monitoring Receiver Market 133
7.3.1.2 Personal Continuous Glucose Monitoring Transmitter Market 135
7.3.1.3 Personal Continuous Glucose Monitoring Sensor Market 138
7.3.2 Total Professional Continuous Glucose Monitoring Market 140
7.3.2.1 Professional Continuous Glucose Monitoring System Market 144
7.3.2.2 Professional Continuous Glucose Monitoring Transmitter Market 146
7.3.2.3 Professional Continuous Glucose Monitoring Sensor Market 148
7.3.3 Emerging Markets: Non-Invasive CGM 150
7.4 DRIVERS AND LIMITERS 151
7.4.1 Market Drivers 151
7.4.2 Market Limiters 153
7.5 COMPETITIVE MARKET SHARE ANALYSIS 155
INSULIN MARKET 159
8.1 INTRODUCTION 159
8.1.1 Insulin Types 159
8.1.1.1 Rapid-Acting Insulin Analogs 159
8.1.1.2 Regular Human Insulin 160
8.1.1.3 Intermediate-Acting Human Insulin 160
8.1.1.4 Long-Acting Insulin Analogs 160
8.1.1.5 Ultra-Long-Acting Insulin Analogs 160
8.1.1.6 Premixed Insulin 160
8.2 MARKET OVERVIEW 162
8.3 MARKET ANALYSIS AND FORECAST 166
8.3.1 Total Insulin Market 166
8.3.1.1 Long-Acting Insulin Market 169
8.3.1.2 Rapid-Acting Insulin Market 172
8.3.1.3 Premixed Insulin Market 175
8.3.1.4 Human Insulin Market 177
8.4 DRIVERS AND LIMITERS 179
8.4.1 Market Drivers 179
8.4.2 Market Limiters 180
8.5 COMPETITIVE MARKET SHARE ANALYSIS 182
INSULIN PEN MARKET 185
9.1 INTRODUCTION 185
9.2 MARKET OVERVIEW 187
9.3 MARKET ANALYSIS AND FORECAST 191
9.3.1 Prefilled Insulin Pen Market 191
9.3.2 Insulin Pen Cartridge Market 194
9.3.3 Reusable Insulin Pen Market 197
9.3.4 Total Insulin Pen Needle Market 200
9.3.4.1 Conventional Insulin Pen Needle Market 203
9.3.4.2 Safety Insulin Pen Needle Market 206
9.4 DRIVERS AND LIMITERS 208
9.4.1 Market Drivers 208
9.4.2 Market Limiters 210
9.5 COMPETITIVE MARKET SHARE ANALYSIS 212
INSULIN SYRINGE MARKET 216
10.1 INTRODUCTION 216
10.2 MARKET OVERVIEW 217
10.3 MARKET ANALYSIS AND FORECAST 221
10.3.1 Total Insulin Syringe Market 221
10.3.1.1 Conventional Insulin Syringe Market 224
10.3.1.2 Safety Insulin Syringe Market 227
10.4 DRIVERS AND LIMITERS 230
10.4.1 Market Drivers 230
10.4.2 Market Limiters 230
10.5 COMPETITIVE MARKET SHARE ANALYSIS 234
INSULIN PUMP MARKET 237
11.1 INTRODUCTION 237
11.1.1 Traditional Insulin Pumps 237
11.1.2 Patch Insulin Pumps 237
11.1.3 Simple Insulin Pumps 238
11.2 MARKET OVERVIEW 239
11.3 MARKET ANALYSIS AND FORECAST 243
11.3.1 Total Traditional Insulin Pump Market 243
11.3.1.1 Traditional Insulin Pump Market 247
11.3.1.2 Infusion Set Market 249
11.3.1.3 Pump Reservoir Market 251
11.3.2 Total Patch Insulin Pump Market 253
11.3.2.1 Patch Pump System Market 257
11.3.2.2 Insulin Pod Market 259
11.3.3 Simple Insulin Pump Market 261
11.4 DRIVERS AND LIMITERS 264
11.4.1 Market Drivers 264
11.4.2 Market Limiters 266
11.5 COMPETITIVE MARKET SHARE ANALYSIS 268
ABBREVIATIONS 272

LIST OF CHARTS
Chart 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 -2023 3
Chart 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Overview, U.S., 2013 &2023 3
Chart 3 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 -2023 43
Chart 3 2: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S., 2016 44
Chart 3 3: Diabetes Monitoring, Treatment and Drug Delivery Market Breakdown, U.S.,2023 44
Chart 3 4: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 -2023 48
Chart 3 5: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 56
Chart 4 1: Blood Glucose Meter Market by Segment, U.S., 2013 -2023 62
Chart 4 2: Blood Glucose Meter Market Breakdown, U.S., 2016 63
Chart 4 3: Blood Glucose Meter Market Breakdown, U.S.,2023 63
Chart 4 4: Total Blood Glucose Meter Market, U.S., 2013 -2023 65
Chart 4 5: Personal Blood Glucose Meter Market, U.S., 2013 -2023 68
Chart 4 6: Professional Blood Glucose Meter Market, U.S., 2013 -2023 70
Chart 4 7: Leading Competitors, Blood Glucose Meter Market, U.S., 2016 77
Chart 5 1: Blood Glucose Test Strip Market by Segment, U.S., 2013 -2023 81
Chart 5 2: Blood Glucose Test Strip Market Breakdown, U.S., 2016 82
Chart 5 3: Blood Glucose Test Strip Market Breakdown, U.S.,2023 82
Chart 5 4: Total Blood Glucose Test Strip Market, U.S., 2013 -2023 84
Chart 5 5: Total Personal Blood Glucose Test Strip Market, U.S., 2013 -2023 87
Chart 5 6: Total Personal Blood Glucose Test Strip Market Breakdown, U.S., 2016 88
Chart 5 7: Total Personal Blood Glucose Test Strip Market Breakdown, U.S.,2023 88
Chart 5 8: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2013 -2023 90
Chart 5 9: Managed Care Blood Glucose Test Strip Market, U.S., 2013 -2023 92
Chart 5 10: Cash Blood Glucose Test Strip Market, U.S., 2013 -2023 94
Chart 5 11: Professional Blood Glucose Test Strip Market, U.S., 2013 -2023 96
Chart 5 12: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2016 103
Chart 6 1: Lancet and Lancing Device Market by Segment, U.S., 2013 -2023 107
Chart 6 2: Lancet and Lancing Device Market Breakdown, U.S., 2016 108
Chart 6 3: Lancet and Lancing Device Market Breakdown, U.S.,2023 108
Chart 6 4: Total Lancet and Lancing Device Market, U.S., 2013 -2023 110
Chart 6 5: Personal Lancet and Lancing Device Market, U.S., 2013 -2023 113
Chart 6 6: Professional Lancet and Lancing Device Market, U.S., 2013 -2023 115
Chart 6 7: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016 122
Chart 7 1: Continuous Glucose Monitoring Market by Segment, U.S., 2013 -2023 127
Chart 7 2: Continuous Glucose Monitoring Market Breakdown, U.S., 2016 128
Chart 7 3: Continuous Glucose Monitoring Market Breakdown, U.S.,2023 128
Chart 7 4: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013 -2023 131
Chart 7 5: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S., 2016 132
Chart 7 6: Total Personal Continuous Glucose Monitoring Market Breakdown, U.S.,2023 132
Chart 7 7: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013 - 2023 134
Chart 7 8: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013 - 2023 137
Chart 7 9: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013 - 2023 139
Chart 7 10: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013 - 2023 142
Chart 7 11: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S., 2016 143
Chart 7 12: Total Professional Continuous Glucose Monitoring Market Breakdown, U.S.,2023 143
Chart 7 13: Professional Continuous Glucose Monitoring System Market, U.S., 2013 -2023 145
Chart 7 14: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013 -2023 147
Chart 7 15: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013 -2023 149
Chart 7 16: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016 158
Chart 8 1: Insulin Market by Segment, U.S., 2013 -2023 164
Chart 8 2: Insulin Market Breakdown, U.S., 2016 165
Chart 8 3: Insulin Market Breakdown, U.S.,2023 165
Chart 8 4: Total Insulin Market, U.S., 2013 - 2023 168
Chart 8 5: Long-Acting Insulin Market, U.S., 2013 - 2023 171
Chart 8 6: Rapid-Acting Insulin Market, U.S., 2013 -2023 174
Chart 8 7: Premixed Insulin Market, U.S., 2013 -2023 176
Chart 8 8: Human Insulin Market, U.S., 2013 -2023 178
Chart 8 9: Leading Competitors, Insulin Market, U.S., 2016 184
Chart 9 1: Insulin Pen Market by Segment, U.S., 2013 -2023 189
Chart 9 2: Insulin Pen Market Breakdown, U.S., 2016 190
Chart 9 3: Insulin Pen Market Breakdown, U.S.,2023 190
Chart 9 4: Prefilled Insulin Pen Market, U.S., 2013 -2023 193
Chart 9 5: Insulin Pen Cartridge Market, U.S., 2013 -2023 196
Chart 9 6: Reusable Insulin Pen Market, U.S., 2013 -2023 199
Chart 9 7: Total Insulin Pen Needle Market, U.S., 2013 -2023 201
Chart 9 8: Total Insulin Pen Needle Market Breakdown, U.S., 2016 202
Chart 9 9: Total Insulin Pen Needle Market Breakdown, U.S.,2023 202
Chart 9 10: Conventional Insulin Pen Needle Market, U.S., 2013 -2023 205
Chart 9 11: Safety Insulin Pen Needle Market, U.S., 2013 -2023 207
Chart 9 12: Leading Competitors, Insulin Pen Market, U.S., 2016 215
Chart 10 1: Insulin Syringe Market by Segment, U.S., 2013 -2023 219
Chart 10 2: Insulin Syringe Market Breakdown, U.S., 2016 220
Chart 10 3: Insulin Syringe Market Breakdown, U.S.,2023 220
Chart 10 4: Total Insulin Syringe Market, U.S., 2013 -2023 223
Chart 10 5: Conventional Insulin Syringe Market, U.S., 2013 - 2023 226
Chart 10 6: Safety Insulin Syringe Market, U.S., 2013 -2023 229
Chart 10 7: Leading Competitors, Insulin Syringe Market, U.S., 2016 236
Chart 11 1: Insulin Pump Market by Segment, U.S., 2013 -2023 241
Chart 11 2: Insulin Pump Market Breakdown, U.S., 2016 242
Chart 11 3: Insulin Pump Market Breakdown, U.S.,2023 242
Chart 11 4: Total Traditional Insulin Pump Market by Segment, U.S., 2013 - 2023 245
Chart 11 5: Total Traditional Insulin Pump Market Breakdown, U.S., 2016 246
Chart 11 6: Total Traditional Insulin Pump Market Breakdown, U.S., 2023 246
Chart 11 7: Traditional Insulin Pump Market, U.S., 2013 -2023 248
Chart 11 8: Infusion Set Market, U.S., 2013 -2023 250
Chart 11 9: Pump Reservoir Market, U.S., 2013 -2023 252
Chart 11 10: Total Patch Insulin Pump Market by Segment, U.S., 2013 -2023 255
Chart 11 11: Total Patch Insulin Pump Market Breakdown, U.S., 2016 256
Chart 11 12: Total Patch Insulin Pump Market Breakdown, U.S.,2023 256
Chart 11 13: Patch Pump System Market, U.S., 2013 -2023 258
Chart 11 14: Insulin Pod Market, U.S., 2013 -2023 260
Chart 11 15: Simple Insulin Pump Market, U.S., 2013 -2023 263
Chart 11 16: Leading Competitors, Insulin Pump Market, U.S., 2016 271

LIST OF FIGURES
Figure 1 1: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (1 of 2) 4
Figure 1 2: Diabetes Monitoring, Treatment and Drug Delivery Market Share Ranking by Segment, U.S., 2016 (2 of 2) 4
Figure 1 3: Companies Researched in this Report, U.S., 2016 6
Figure 1 4: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (1 of 2) 7
Figure 1 5: Factors Impacting the Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S. (2 of 2) 8
Figure 1 6: Recent Events in the Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 - 2016 9
Figure 1 7: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 10
Figure 1 8: Procedure Codes Investigated, U.S., 2016 11
Figure 1 9: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (1 of 2) 12
Figure 1 10: Diabetes Monitoring, Treatment and Drug Delivery Markets Covered, U.S., 2016 (2 of 2) 13
Figure 1 11: Key Report Updates 14
Figure 1 12: Version History 14
Figure 2 1: Major Types of Diabetes and Related Pathologies, U.S., 2016 28
Figure 2 2: Risk Factors Associated with Type 1 and Type 2 Diabetes, U.S., 2016 32
Figure 2 3: Signs and Symptoms Associated with Type 1 and Type 2 Diabetes, U.S., 2016 33
Figure 3 1: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 -2023 (US$M) (1 of 2) 41
Figure 3 2: Diabetes Monitoring, Treatment and Drug Delivery Market by Segment, U.S., 2013 -2023 (US$M) (2 of 2) 42
Figure 3 3: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 -2023 (1 of 2) 47
Figure 3 4: Growth Rates by Segment, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2013 -2023 (2 of 2) 47
Figure 3 5: Drivers and Limiters, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 52
Figure 3 6: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 (1 of 2) 54
Figure 3 7: Leading Competitors, Diabetes Monitoring, Treatment and Drug Delivery Market, U.S., 2016 (2 of 2) 55
Figure 4 1: Blood Glucose Range Guidelines by the American Diabetes Association, U.S., 2016 59
Figure 4 2: Blood Glucose Meter Market by Segment, U.S., 2013 -2023 (US$M) 61
Figure 4 3: Total Blood Glucose Meter Market, U.S., 2013 -2023 64
Figure 4 4: Personal Blood Glucose Meter Market, U.S., 2013 -2023 66
Figure 4 5: Professional Blood Glucose Meter Market, U.S., 2013 -2023 69
Figure 4 6: Drivers and Limiters, Blood Glucose Meter Market, U.S., 2016 73
Figure 4 7: Leading Competitors, Blood Glucose Meter Market, U.S., 2016 76
Figure 5 1: Blood Glucose Test Strip Market by Segment, U.S., 2013 -2023 (US$M) 80
Figure 5 2: Total Blood Glucose Test Strip Market, U.S., 2013 -2023 83
Figure 5 3: Total Personal Blood Glucose Test Strip Market, U.S., 2013 -2023 86
Figure 5 4: Medicare/Medicaid Blood Glucose Test Strip Market, U.S., 2013 -2023 89
Figure 5 5: Managed Care Blood Glucose Test Strip Market, U.S., 2013 -2023 91
Figure 5 6: Cash Blood Glucose Test Strip Market, U.S., 2013 -2023 93
Figure 5 7: Professional Blood Glucose Test Strip Market, U.S., 2013 -2023 95
Figure 5 8: Drivers and Limiters, Blood Glucose Test Strip Market, U.S., 2016 99
Figure 5 9: Leading Competitors, Blood Glucose Test Strip Market, U.S., 2016 102
Figure 6 1: Lancet and Lancing Device Market by Segment, U.S., 2013 -2023 (US$M) 106
Figure 6 2: Total Lancet and Lancing Device Market, U.S., 2013 -2023 109
Figure 6 3: Personal Lancet and Lancing Device Market, U.S., 2013 -2023 112
Figure 6 4: Professional Lancet and Lancing Device Market, U.S., 2013 -2023 114
Figure 6 5: Drivers and Limiters, Lancet and Lancing Device Market, U.S., 2016 118
Figure 6 6: Leading Competitors, Lancet and Lancing Device Market, U.S., 2016 120
Figure 7 1: Continuous Glucose Monitoring Market by Segment, U.S., 2013 -2023 (US$M) 126
Figure 7 2: Total Personal Continuous Glucose Monitoring Market by Segment, U.S., 2013 -2023 (US$M) 130
Figure 7 3: Personal Continuous Glucose Monitoring Receiver Market, U.S., 2013 - 2023 133
Figure 7 4: Personal Continuous Glucose Monitoring Transmitter Market, U.S., 2013 - 2023 136
Figure 7 5: Personal Continuous Glucose Monitoring Sensor Market, U.S., 2013 - 2023 138
Figure 7 6: Total Professional Continuous Glucose Monitoring Market by Segment, U.S., 2013 - 2023 (US$M) 141
Figure 7 7: Professional Continuous Glucose Monitoring System Market, U.S., 2013 -2023 144
Figure 7 8: Professional Continuous Glucose Monitoring Transmitter Market, U.S., 2013 -2023 146
Figure 7 9: Professional Continuous Glucose Monitoring Sensor Market, U.S., 2013 -2023 148
Figure 7 10: Drivers and Limiters, Continuous Glucose Monitoring Market, U.S., 2016 154
Figure 7 11: Leading Competitors, Continuous Glucose Monitoring Market, U.S., 2016 157
Figure 7 1: Onset, Peak and Duration of Insulin Types, U.S., 2016 161
Figure 8 2: Insulin Market by Segment, U.S., 2013 -2023 (US$M) 163
Figure 8 3: Total Insulin Market, U.S., 2013 -2023 167
Figure 8 4: Long-Acting Insulin Market, U.S., 2013 - 2023 170
Figure 8 5: Rapid-Acting Insulin Market, U.S., 2013 -2023 173
Figure 8 6: Premixed Insulin Market, U.S., 2013 -2023 175
Figure 8 7: Human Insulin Market, U.S., 2013 -2023 177
Figure 8 8: Drivers and Limiters, Insulin Market, U.S., 2016 181
Figure 8 9: Leading Competitors, Insulin Market, U.S., 2016 183
Figure 9 1: Insulin Pen Market by Segment, U.S., 2013 -2023 (US$M) 188
Figure 9 2: Prefilled Insulin Pen Market, U.S., 2013 -2023 192
Figure 9 3: Insulin Pen Cartridge Market, U.S., 2013 -2023 195
Figure 9 4: Reusable Insulin Pen Market, U.S., 2013 -2023 198
Figure 9 5: Total Insulin Pen Needle Market by Segment, U.S., 2013 -2023 (US$M) 200
Figure 9 6: Conventional Insulin Pen Needle Market, U.S., 2013 -2023 203
Figure 9 7: Safety Insulin Pen Needle Market, U.S., 2013 -2023 206
Figure 9 8: Drivers and Limiters, Insulin Pen Market, U.S., 2016 211
Figure 9 9: Leading Competitors, Insulin Pen Market, U.S., 2016 214
Figure 10 1: Insulin Syringe Market by Segment, U.S., 2013 - 2023 (US$M) 218
Figure 10 2: Total Insulin Syringe Market, U.S., 2013 -2023 222
Figure 10 3: Conventional Insulin Syringe Market, U.S., 2013 - 2023 225
Figure 10 4: Safety Insulin Syringe Market, U.S., 2013 -2023 228
Figure 10 5: Drivers and Limiters, Insulin Syringe Market, U.S., 2016 233
Figure 10 6: Leading Competitors, Insulin Syringe Market, U.S., 2016 235
Figure 11 1: Insulin Pump Market by Segment, U.S., 2013 -2023 (US$M) 240
Figure 11 2: Total Traditional Insulin Pump Market by Segment, U.S., 2013 - 2023 (US$M) 244
Figure 11 3: Traditional Insulin Pump Market, U.S., 2013 - 2023 247
Figure 11 4: Infusion Set Market, U.S., 2013 - 2023 249
Figure 11 5: Pump Reservoir Market, U.S., 2013 - 2023 251
Figure 11 6: Total Patch Insulin Pump Market by Segment, U.S., 2013 - 2023 (US$M) 254
Figure 11 7: Patch Pump System Market, U.S., 2013 -2023 257
Figure 11 8: Insulin Pod Market, U.S., 2013 -2023 259
Figure 11 9: Simple Insulin Pump Market, U.S., 2013 -2023 261
Figure 11 10: Drivers and Limiters, Insulin Pump Market, U.S., 2016 267
Figure 11 11: Leading Competitors, Insulin Pump Market, U.S., 2016 270


If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.